Johnson & Johnson Backgrounder
By caring for the world, one person at a time we aspire to help billions of people live longer, healthier, happier lives. This aspiration inspires and unites the approximately 128,000 employees of Johnson & Johnson across more than 275 operating companies in 60 countries. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. For more than 125 years, the Johnson & Johnson Family of Companies has been committed to caring for people around the world. With $67 billion in 2012 sales, Johnson & Johnson, through its family of companies, is the worlds most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. Financial results for 2012 reflected continued sales momentum in many parts of the business driven by a focus on delivering meaningful innovation in health care to patients and customers. Johnson & Johnson has achieved 29 consecutive years of adjusted earnings* increases and 51 consecutive years** of dividend increases. Its enduring market leadership in health care is illustrated by the fact that about 70 percent of its sales in 2012 came from products with No. 1 or No. 2 global market share positions. Approximately 25 percent of 2012 sales came from new products introduced in the last five years.
Our Philosophy
At the foundation of our business is a fundamental commitment to Our Credo, which was written in 1943 by Robert Wood Johnson, then Chief Executive Officer and son of one of the Companys founders. Our Credo eloquently defines the common values of our employees and establishes the business values and philosophy that guide all our operating companies worldwide. Our Credo puts patients and customers first, then our employees, our communities and our shareholders. With Our Credo as a foundation, our long-standing operating model has four strategic principles: being broadly based in human health; managing our business for the long term; taking a decentralized management approach; and focusing on our people and values. In todays highly competitive global marketplace, it is also essential that we focus on the critical drivers of our future growth: to create value through innovation, to extend our global reach with local focus, to execute with excellence in everything we do, and to inspire leadership with purpose among the people who carry on the Johnson & Johnson legacy.
Our Businesses
Our Family of Companies comprises: The worlds largest medical device company The worlds sixth-largest biologics company The worlds sixth-largest consumer health company The worlds eighth-largest pharmaceuticals company
The Medical Devices and Diagnostics segment produces a broad range of innovative products used primarily by health care professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, diagnostics, cardiovascular disease, sports medicine, and aesthetics. The Pharmaceutical segments broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience & pain, and oncology. The Consumer segment includes a broad range of products used in the baby care, skin care, oral care, wound care and womens health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. Across all our businesses, the leadership of Johnson & Johnson is looking toward the future with a clear understanding of the challenges and with excitement about the extraordinary opportunities that exist to improve the quality of peoples lives around the world.
Our Social Responsibility
Johnson & Johnson works to be an exemplary corporate citizen collaborating with others to address important issues society faces. Our primary focus is on making life-changing, long-term differences in human health by targeting the worlds major health-related issues. We work to fulfill this goal, and other philanthropic efforts, through community-based partnerships in six broad areas of health care in which we and our external stakeholders believe that Johnson & Johnson plays a leadership role. These include: womens and childrens health; global health coordination; wellness and prevention; health care education and delivery; drug treatment development; and enhancing health care systems. The Company recognizes the critical interdependence between human health and the health of our planet. We are committed to reducing environmental impacts across all aspects of operations and our vision is driven by long-term environmental goals, policies and performance standards. Our commitment is supported by a comprehensive environmental management structure, a system of certification and assessment processes, and company-wide accountability for progress against our goals. In 2012, Johnson & Johnson contributed more than $900 million in cash and products towards nearly 600 programs in more than 50 countries, impacting tens of millions of lives worldwide. * Excludes special items ** As of April 25, 2013 August 2013
